-
UPDATE: Sterne Agee Raises Price Target on OFG Bancorp on Recent BBVAPR Transaction
Wednesday, July 31, 2013 - 2:16pm | 115In a report published on Wednesday, Sterne Agee analyst Todd Hagerman raised the price target on OFG Bancorp (NYSE: OFG) from $20.00 to $23.00 and reiterated a Buy rating on the company. In the report, Sterne Agee Stated, "The benefits of the recent BBVAPR transaction continue to shine,...
-
EA Could Replace Zynga As 15% of Facebook's Revenue
Monday, May 7, 2012 - 1:03pm | 370Analyst Arvind Bhatia of Sterne Agee says he doubts Zynga (NASDAQ: ZNGA) will be 15% of Facebook's (NASDAQ: FB) revenue in the future. Bhatia explains, “Facebook's own revenue is going to continue to grow at a much higher pace than Zynga's revenue.” Bhatia says he believes Electronic Arts (NASDAQ:...
-
Sterne Agee Downgrades StanCorp Financial Group to Underperform
Monday, January 9, 2012 - 10:18am | 28Sterne Agee has downgraded StanCorp Financial Group (NYSE: SFG) from Neutral to Underperform and has raised the price target to $37.
-
Sterne Agee Upgrades SCBT Financial to Buy
Monday, January 9, 2012 - 10:16am | 24Sterne Agee has upgraded SCBT Financial (NASDAQ: SCBT) from Neutral to Buy with a $35 price target.
-
Sterne Agee Downgrades Reinsurance Group of America to Neutral
Monday, January 9, 2012 - 10:14am | 27Sterne Agee has downgraded Reinsurance Group of America (NYSE: RGA) from Buy to Neutral and has a $62 price target.
-
Sterne Agee Downgrades Reinsurance Group of America to Neutral
Monday, January 9, 2012 - 10:14am | 27Sterne Agee has downgraded Reinsurance Group of America (NYSE: RGA) from Buy to Neutral and has a $62 price target.
-
Sterne Agee Initiates PVH at Buy
Monday, January 9, 2012 - 10:11am | 25Sterne Agee has initiated coverage on PVH Corporation (NYSE: PVH) with a Buy rating and $85 price target.
-
Sterne Agee Maintains Buy, PT of $43 on Charles River Laboratories
Monday, December 5, 2011 - 8:38am | 121Sterne Agee reiterates its Buy rating and price target of $43 on Charles River Laboratories (NYSE: CRL) as sentiment around the stock is low. Sterne Agee says, “After meeting multiple investors recently, we believe sentiment towards CRL shares is extremely low, which we attribute to CRL...
-
Sterne Agee Maintains Buy, $7 PT on Albany Molecular Research
Monday, December 5, 2011 - 8:33am | 92Sterne Agee reiterates its Buy rating and $7 price target on Albany Molecular Research, Inc. (NASDAQ: AMRI) as the current valuation discounts a $200MM business. Sterne Agee says, “In our view, AMRI's current valuation solely reflects the net present value of future Allegra royalties, which we...
-
UPDATE: Sterne Agee Downgrades Cash America International to Neutral
Friday, December 2, 2011 - 8:51am | 111A report from Sterne Agee downgrades its rating to Neutral and reiterates its $53 price target on Cash America International (NYSE: CSH). The report states, “On Thursday, following hearings first initiated on October 18th, the Back Bench Business Committee held further hearings on the debt...
-
UPDATE: Sterne Agee Upgrades Analog Devices to Buy
Friday, December 2, 2011 - 8:47am | 84A report from Sterne Agee upgrades its rating to Buy with a $42 price target on Analog Devices Inc. (NYSE: ADI). The report states, “A combination of leaner industrial channel inventories and order stabilization into 1Q12 in U.S.-China and a restorationrecovery in communication orders post the...
-
Sterne Agee Maintains Neutral, $83 Target on 3M
Wednesday, November 30, 2011 - 11:53am | 126In a flash note, Sterne Agee reiterates its Neutral rating and $83 target price on 3M Co. (NYSE: MMM) as display and graphic data points are not encouraging for the company. Sterne Agee notes, “Lower tablet and TV sales will be a negative for MMM's Display and Graphics segment, which we currently...
-
Sterne Agee Maintains Buy, $90 Target on Under Armour
Wednesday, November 30, 2011 - 8:37am | 141In a flash note, Sterne Agee reiterates its Buy rating, $90 target on Under Armour, Inc. (NYSE: UA) as new products drive sales and cover price increases but inflation costs may pressure margins. Sterne Agee says, “The increase in retail price points is not enough to offset the cost inflation....
-
Sterne Agee Reiterates Buy, $30 Target on GameStop
Wednesday, November 30, 2011 - 8:30am | 89In a company report, Sterne Agee maintains its Buy rating and $30 target price on GameStop Corp. (NYSE: GME) as November trends bode well for the remaining holiday period. Sterne Agee says, “We believe several factors could drive the stock higher in the near term including: 1) potentially good...
-
Sterne Agee Expecting Upside for Tiffany & Co. Through Holiday Season
Tuesday, November 29, 2011 - 1:42pm | 152Sterne Agee has published a research report on Tiffany & Co. (NYSE: TIF) after the company reported its strong 3Q earnings today. In the report, Sterne Agee writes, "Following a strong Q3 report which exceeded estimates by $0.10, TIF increased its yearly guidance range by $0.05 to $3.70-$3.80...